Welcome to the Bayer Combination Aspirin Litigation Settlement website

If you purchased either of the listed Bayer Combination Aspirin Products in the U.S. for personal, family or household uses within the specific time stated, then you are a member of a Settlement Class. 

Plaintiffs claim that Bayer overcharged consumers for Bayer® Aspirin With Heart Advantage and Bayer® Women’s Low-Dose Aspirin + Calcium (“Combination Aspirin Products”) or that these products should not have been sold, because these products were not FDA-approved, could not provide all advertised health benefits and were inappropriate for long-term use.  Bayer denies it did anything wrong.  The Court has not decided who is right and who is wrong. Bayer has agreed to make payments totaling $15,000,000.00 to settle Plaintiffs’ claims, including attorneys’ fees and costs.  

Initial settlement payments mailed in 2013. A supplemental settlement payment will mail on June 2, 2021.

If you have questions please call 1-877-257-5766, or write to Bayer Combination Aspirin Litigation Settlement Administrator at P.O. Box 43009, Providence RI 02940-3009 or email info@bayercombinationaspirinsettlement.com.